| Progress in inflammatory breast cancer: cause for cautious optimism |
| GN Hortobagyi and AU Buzdar |
|
JCO Dec 1 1986: 1727–1729.
[PDF]
|
 |
| Bench-to-bedside research and the human tumor stem-cell assay--bridging the credibility gap |
| GP Browman, MN Levine, and RS Roberts |
|
JCO Dec 1 1986: 1730–1731.
[PDF]
|
|
|
Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine |
| |
SB Murphy, WP Bowman, M Abromowitch, J Mirro, J Ochs, G Rivera, CH Pui, D Fairclough, and CW Berard |
| |
JCO Dec 1 1986: 1732–1739.
[Abstract]
[PDF]
|
|
|
Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length |
| |
R Ohno, Y Kato, E Nagura, T Murase, M Okumura, H Yamada, M Ogura, S Minami, H Suzuki, and Y Morishima |
| |
JCO Dec 1 1986: 1740–1747.
[Abstract]
[PDF]
|
|
|
Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features |
| |
HM Kantarjian, MJ Keating, RS Walters, TL Smith, A Cork, KB McCredie, and EJ Freireich |
| |
JCO Dec 1 1986: 1748–1757.
[Abstract]
[PDF]
|
|
|
Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood |
| |
JM Chessells, J Durrant, RM Hardy, and S Richards |
| |
JCO Dec 1 1986: 1758–1764.
[Abstract]
[PDF]
|
|
|
Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy |
| |
J Rouesse, S Friedman, D Sarrazin, H Mouriesse, T Le Chevalier, R Arriagada, M Spielmann, A Papacharalambous, and F May-Levin |
| |
JCO Dec 1 1986: 1765–1771.
[Abstract]
[PDF]
|
|
|
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer |
| |
RD Gelber and A Goldhirsch |
| |
JCO Dec 1 1986: 1772–1779.
[Abstract]
[PDF]
|
|
|
A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma |
| |
J Klastersky, JP Sculier, P Ravez, P Libert, J Michel, G Vandermoten, P Rocmans, Y Bonduelle, M Mairesse, and T Michiels |
| |
JCO Dec 1 1986: 1780–1786.
[Abstract]
[PDF]
|
|
|
High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer |
| |
DR Gandara, MW DeGregorio, H Wold, BJ Wilbur, M Kohler, HJ Lawrence, AB Deisseroth, and CB George |
| |
JCO Dec 1 1986: 1787–1793.
[Abstract]
[PDF]
|
|
|
Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group |
| |
|
| |
JCO Dec 1 1986: 1794–1798.
[Abstract]
[PDF]
|
|
|
An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer |
| |
J Wils, H Bleiberg, O Dalesio, G Blijham, N Mulder, A Planting, T Splinter, and N Duez |
| |
JCO Dec 1 1986: 1799–1803.
[Abstract]
[PDF]
|
|
|
High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study |
| |
O Hartmann, E Benhamou, F Beaujean, JL Pico, C Kalifa, C Patte, F Flamant, and J Lemerle |
| |
JCO Dec 1 1986: 1804–1810.
[Abstract]
[PDF]
|
|
|
High-dose chemotherapy without autologous bone marrow transplantation in melanoma |
| |
NS Tchekmedyian, N Tait, D Van Echo, and J Aisner |
| |
JCO Dec 1 1986: 1811–1818.
[Abstract]
[PDF]
|
|
|
Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard) |
| |
MH Shiu, WH Knapper, JG Fortner, S Yeh, G Horowitz, J Schnog, J Guerra, P Gould- Rossbach, and C Ray |
| |
JCO Dec 1 1986: 1819–1826.
[Abstract]
[PDF]
|
|
|
Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens |
| |
DD Von Hoff, GM Clark, GR Weiss, MH Marshall, JB Buchok, WA Knight, 3d, and CF LeMaistre |
| |
JCO Dec 1 1986: 1827–1834.
[Abstract]
[PDF]
|
|
|
Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer |
| |
EK Rowinsky, DS Ettinger, LB Grochow, RB Brundrett, AE Cates, and RC Donehower |
| |
JCO Dec 1 1986: 1835–1844.
[Abstract]
[PDF]
|
|
|
Transient cerebral dysfunction secondary to high-dose methotrexate |
| |
RW Walker, JC Allen, G Rosen, and B Caparros |
| |
JCO Dec 1 1986: 1845–1850.
[Abstract]
[PDF]
|
|
|
Surgical treatment of spinal cord compression in kidney cancer |
| |
N Sundaresan, H Scher, GV DiGiacinto, A Yagoda, W Whitmore, and IS Choi |
| |
JCO Dec 1 1986: 1851–1856.
[Abstract]
[PDF]
|
|
|
A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes |
| |
BD Cheson, DM Jasperse, R Simon, and MA Friedman |
| |
JCO Dec 1 1986: 1857–1864.
[Abstract]
[PDF]
|
|
| Dose intensity and response |
|
|
JCO Dec 1 1986: 1865–1866.
[PDF]
|
|
| Treatment of non-Hodgkin's lymphoma in the elderly |
| V Zagonel, U Tirelli, and A Carbone |
|
JCO Dec 1 1986: 1866–1867.
[PDF]
|
|
| Acute toxicity of epirubicin |
| GB Zulian |
|
JCO Dec 1 1986: 1867–1868.
[PDF]
|
|
| High-dose cytosine arabinoside with amsacrine for treatment of acute lymphoblastic leukemia |
| ZA Arlin |
|
JCO Dec 1 1986: 1868.
[PDF]
|
|
